Clinical Trial Update: SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer [NA]

View source ↗

Summary

This clinical trial is evaluating the combination of stereotactic radiotherapy (SRT) with anlotinib for brain metastases from non-small cell lung cancer. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)

Snippet

Sponsor: The First People's Hospital of Lianyungang | Conditions: Non-Small-Cell Lung Cancer, Brain Metastases | NA | Status: RECRUITING